819 related articles for article (PubMed ID: 16001983)
1. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
2. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
3. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
Sarau HM; Rush JA; Foley JJ; Brawner ME; Schmidt DB; White JR; Barnette MS
J Pharmacol Exp Ther; 1997 Oct; 283(1):411-8. PubMed ID: 9336350
[TBL] [Abstract][Full Text] [Related]
4. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
7. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
8. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
Proost P; Struyf S; Couvreur M; Lenaerts JP; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J
J Immunol; 1998 Apr; 160(8):4034-41. PubMed ID: 9558113
[TBL] [Abstract][Full Text] [Related]
9. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
Ruffing N; Sullivan N; Sharmeen L; Sodroski J; Wu L
Cell Immunol; 1998 Nov; 189(2):160-8. PubMed ID: 9790730
[TBL] [Abstract][Full Text] [Related]
10. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
11. Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes.
Møller AS; Øvstebø R; Westvik AB; Joø GB; Haug KB; Kierulf P
J Endotoxin Res; 2003; 9(6):349-60. PubMed ID: 14733721
[TBL] [Abstract][Full Text] [Related]
12. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.
Uguccioni M; D'Apuzzo M; Loetscher M; Dewald B; Baggiolini M
Eur J Immunol; 1995 Jan; 25(1):64-8. PubMed ID: 7531149
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
14. T helper 1 and T helper 2 cells respond differentially to chemokines.
Siveke JT; Hamann A
J Immunol; 1998 Jan; 160(2):550-4. PubMed ID: 9551886
[TBL] [Abstract][Full Text] [Related]
15. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
[TBL] [Abstract][Full Text] [Related]
16. Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody.
Reid C; Rushe M; Jarpe M; van Vlijmen H; Dolinski B; Qian F; Cachero TG; Cuervo H; Yanachkova M; Nwankwo C; Wang X; Etienne N; Garber E; Bailly V; de Fougerolles A; Boriack-Sjodin PA
Protein Eng Des Sel; 2006 Jul; 19(7):317-24. PubMed ID: 16682434
[TBL] [Abstract][Full Text] [Related]
17. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
18. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
19. Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2.
O'Boyle G; Brain JG; Kirby JA; Ali S
Mol Immunol; 2007 Mar; 44(8):1944-53. PubMed ID: 17081610
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of two murine eosinophil beta chemokine receptors.
Post TW; Bozic CR; Rothenberg ME; Luster AD; Gerard N; Gerard C
J Immunol; 1995 Dec; 155(11):5299-305. PubMed ID: 7594543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
